John Paul Ekwaru

John Paul Ekwaru

Auto-generated profile, based on publicly available information

John Paul Ekwaru

Medlior Health Outcomes Research Ltd., Calgary, AB, Canada

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2017 in Annals of Human Biology
Verified
Journal Article
Closed access
CKCaroline Kroll
Caroline Kroll
SMSilmara Silva Mastroeni
Silmara Silva Mastroeni
SCSandra A. Czarnobay
Sandra A. Czarnobay
JEJohn Paul Ekwaru
John Paul Ekwaru
PVPaul Veugelers
Paul Veugelers
MMMarco Fabio Mastroeni
Marco Fabio Mastroeni
Context: Neck circumference (NC) has been suggested as an alternative measure to screen for excess body weight. Objective: The aim of this study was to demonstrate the accuracy of neck circumference (NC) as a measure for assessing overweight and obesity in both sexes in different age groups. Methods: Detailed individual search strategies were developed for each of the following bibliographic databases: Cochrane, LILACS, PubMed/MEDLINE, Science Direct, Scopus and Web of Science. The QUADAS-2 checklist was used to assess the methodology of the studies included. Results: Thirty-eight assessments were performed in 11 articles according to age, sex and weight status. Using sensitivity and specificity, 27 assessments (71.0%) considered NC an accurate measure to diagnose overweight and obesity. The best sensitivity and specificity were found for the age >19 years (82.0%, 82.0%), female (80.0%, 73.0%), and obese (80.0%, 85.0%) categories. Conclusion: NC is an accurate tool for assessing overweight and obesity in males and females of different age groups and could be used to screen for excess body weight in routine medical practice or epidemiological studies. It is also believed that more studies will permit the creation of a reference dataset of NC cut-off values for world populations.

18 May 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JEJohn Paul Ekwaru
John Paul Ekwaru
AOArto Ohinmaa
Arto Ohinmaa
BTBach Xuan Tran
Bach Xuan Tran
SSSolmaz Setayeshgar
Solmaz Setayeshgar
JJJeffrey A Johnson
Jeffrey A Johnson
PVPaul Veugelers
Paul Veugelers
The Alberta Project Promoting active Living and healthy Eating in Schools (APPLE Schools) has been recognized as a “best practice” in preventing childhood obesity. To inform decision making on the economic implications of APPLE Schools and to justify investment, we evaluated the project’s cost-effectiveness following a life-course approach. We developed a state transition model for the lifetime progression of body weight status comparing elementary school students attending APPLE Schools and control schools. This model quantified the lifetime impact of APPLE Schools in terms of prevention of excess body weight, chronic disease and improved quality-adjusted life years (QALY), from a school system’s cost perspective. Both costs and health outcomes were discounted to their present value using 3% discount rate. The incremental cost-effectiveness ratio(ICER) of APPLE schools was CA$33,421 per QALY gained, and CA$1,555, CA$1,709 and CA$14,218 per prevented person years of excess weight, obesity and chronic disease, respectively. These estimates show that APPLE Schools is cost effective at a threshold of ICER < CA$50,000. In probabilistic sensitivity analysis, APPLE Schools was cost effective more than 64% of the time per QALY gained, when using a threshold of ICER<CA$50,000, and more than 93% of the time when using a threshold of ICER<CA$100,000. School-based health promotion, such as APPLE Schools is a cost-effective intervention for obesity prevention and reduction of chronic disease risk over the lifetime. Expanding the coverage and allocating resources towards school-based programs like the APPLE Schools program, is likely to reduce the public health burden of obesity and chronic diseases.

14 February 2017 in British Journal of Nutrition
Verified
Journal Article
Open access
PDF file
LMLalani L. Munasinghe
Lalani L. Munasinghe
YYYan Yuan
Yan Yuan
NWNoreen Willows
Noreen Willows
EFErin Faught
Erin Faught
JEJohn P. Ekwaru
John P. Ekwaru
PVPaul Veugelers
Paul Veugelers
Recently, countries at high latitudes have updated their vitamin D recommendations to ensure adequate intake for the musculoskeletal health of their respective populations. In 2010, the dietary guidelines for vitamin D for Canadians and Americans aged 1–70 years increased from 5 μg/d to 15 μg/d, whereas in 2016 for citizens of the UK aged ≥4 years 10 μg/d is recommended. The vitamin D status of Canadian children following the revised dietary guidelines is unknown. Therefore, this study aimed to assess the prevalence and determinants of vitamin D deficiency and sufficiency among Canadian children. For this study, we assumed serum 25-hydroxy vitamin D (25(OH)D) concentrations <30 nmol/l as ‘deficient’ and ≥50nmol/l as ‘sufficient’. Data from children aged 3–18 years (n 2270) who participated in the 2012/2013 Canadian Health Measures Survey were analysed. Of all children, 5·6 % were vitamin D deficient and 71 % were vitamin D sufficient. Children who consumed vitamin D-fortified milk daily (77 %) were more likely to be sufficient than those who consumed it less frequently (OR 2·7; 95 % CI 1·4, 5·0). The 9 % of children who reported taking vitamin D-containing supplements in the previous month had higher 25(OH)D concentrations (OR 6·9 nmol/l; 95 % CI 1·1, 12·7 nmol/l) relative to those who did not. Children who were older, obese, of non-white ethnicity and from low-income households were less likely to be vitamin D sufficient. To improve vitamin D status, consumption of vitamin D-rich foods should be promoted, and fortification of more food items or formal recommendations for vitamin D supplementation should be considered.

8 May 2025 in ERJ Open Research
Verified
Journal Article
Open access
PDF file
NHNathaniel M. Hawkins
Nathaniel M. Hawkins
ARArshdeep K. Randhawa
Arshdeep K. Randhawa
CNClementine Nordon
Clementine Nordon
MTManisha Talukdar
Manisha Talukdar
SMSuzanne McMullen
Suzanne McMullen
DSDon D Sin
Don D Sin
Introduction: The EXACOS-CV Canada study described and evaluated treatment patterns, healthcare resource utilisation (HCRU), and costs in patients with COPD who experienced a severe cardiovascular (CV) event or death preceded or not preceded by an exacerbation. Methods: This longitudinal, retrospective cohort study included 142 787 individuals with COPD using administrative data from Alberta, Canada. The index event was a first hospitalisation for a CV event or all-cause death during follow-up. COPD-related treatment, HCRU and costs during the 12-month periods before and after the index events were described. Results: From the initial cohort, 43 564 (30.5%) patients with COPD experienced an index event; 15 100 (34.7%) had a COPD exacerbation in the 12 months prior. Patients whose index event was preceded ( versus not preceded) by an exacerbation were dispensed higher amounts of COPD therapies in the 12 months prior (proportion of dual therapy: 36.9% versus 24.3%; proportion of triple therapy: 54.6% versus 16.3%) and 12 months following the CV event (proportion of dual therapy: 31.7% versus 27.4%; proportion of triple therapy: 53.4% versus 21.1%). Those with a preceding exacerbation also experienced higher rates of hospitalisations, emergency department admissions and general practitioner and specialist physician visits in both the 12 months prior to and following the index event. Discussion: Patients whose index events were preceded versus not preceded by an exacerbation received more treatment regimens and classes of COPD therapy but still incurred more HCRU. Despite the greater healthcare contacts, there remained large treatment gaps in this high-risk population.

1 June 2025 in Clinical Epidemiology
Verified
Journal Article
Open access
PDF file
KRKirsty Marie Rhodes
Kirsty Marie Rhodes
EGEdeltraut Garbe
Edeltraut Garbe
HMHana Müllerová
Hana Müllerová
PEPaul Ekwaru
Paul Ekwaru
NKNils Kossack
Nils Kossack
CNClementine Nordon
Clementine Nordon
Purpose: Multi-database studies may provide heterogeneous results despite using common protocols, leading to challenges in interpretation, but also providing an opportunity to gain insights on populations or healthcare systems. The objectives of these analyses were to develop a framework for exploring sources of statistical heterogeneity and apply it to the multi-database EXACOS-CV (EXAcerbations of COPD and their OutcomeS on CardioVascular diseases) program. Methods: A conceptual framework to systematically assess sources of statistical heterogeneity in multi-database studies was developed. This framework distinguishes between methodological diversity and true clinical variation. Methodological diversity includes differences in study design and database selection, while true variation considers population and healthcare differences. Possible sources of methodological diversity were identified via a novel checklist and explored. In turn, hypotheses were generated about true variation. The framework and checklist were applied to EXACOS-CV cohort studies in Germany, Canada, the Netherlands, and Spain which deviated least from the common protocol and so were included. Focus was on adjusted hazard ratios (aHR) for post-exacerbation associations with decompensated heart failure (HF) and all-cause death, for which results were most and least heterogeneous, respectively. Results: Across EXACOS-CV studies, the adjusted hazard ratios (aHR) for HF in the first 1– 7 days post-exacerbation, compared to non-exacerbation periods, ranged from 2.6 (95% CI, 2.3, 2.9) in Germany to 72.3 (64.4, 81.2) in Canada, and the association with death, relative to non-exacerbation periods, ranged from 3.5 (2.4, 5.3) in the Netherlands to 22.1 (19.9, 24.4) in Spain. Completed methodological diversity checklists linked differences in aHRs to possible variation in ability to capture pre-existing cardiovascular comorbidities across studies, as well as differences in confounder measurement. Standardizing adjusted models across studies did not fully explain heterogeneity, suggesting other contributing factors. Heterogeneity may result from genuine variation in prevalence of CV disease. It was hypothesized that patients with pre-existing CV disease have more accurate diagnoses and management of post-exacerbation CV events, possibly leading to lower risks of such events. Conclusion: Multi-database studies can provide directional insights on the study research question while considering healthcare system and population differences. The developed framework aids assessment of heterogeneity sources.